Bronchial challenge test with mannitol – has it the chance to be the main tool of bronchial reactivity evaluation?
Main Article Content
Abstract
Bronchial hyperreactivity is inseparable, but non-specific feature of asthma. Bronchial challenge tests are used to evidence of bronchial hyperactivity (BHR). A multiple types of these tests were described so far. Methacholine challenge and excercise tests were recognised by ATS, GINA and BTS as standard tools to detecting the BHR. The specialist devices necessary are to their performance. Recently, bronchial challenge test with dry powder of mannitol is promoted. Published papers show the large agreement of results in comparison with the methacholine challenge test. Commercial sets prepared to the test from mannitol allow to conduct it in the every centre making correctly pulmonary function test. Unfortunately, they as yet not are accessible on the market in Poland.
Downloads
Article Details
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. British guideline on the management of asthma 2014 [online: http://www.sing.ac.uk].
3. Remes S.T., Pekkanen J., Remes K. et al.: In search of childhood asthma: questionnaire, tests of bronchial hyperresponsiveness, and clinical evaluation. Thorax 2002, 57(2): 120-126.
4. Siergiejko Z., Świebocka E.: Czy chory na astmę może mieć prawidłową reaktywność oskrzeli? Alergia 2010, 10: 47-49.
5. Anderson S.D., Brannan J., Spring J. et al.: A new methodfor bronchial – provocation testing in asthmatic subjects using a dry powder of mannitol. Am. J. Respir. Crit. Care Med. 1997, 156(3 Pt 1): 758-765.
6. Ulotka z zestawu komercyjnego Aridol.
7. Podlewski J.K., Chwalibogowska-Podlewska A.: Leki współczesnej terapii. Wyd. XX. Split Trading Sp. z o.o., Warszawa 2013.
8. Anderson S.D.: Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010, 138(suppl. 2): 25S-30S.
9. Aitken M.L., Bellon G., De Boeck K. et al.: Long term inhaled dry powder mannitol in cystis fibrosis: an international randomized study. Am. J. Respir. Crit. Care Med. 2012, 185: 645-652.
10. Jaques A., Daviskas E., Turton J.A. et al.: Inhaled mannitol improves lung function in cystis fibrosis. Chest 2008, 133: 1388-1396.
11. Brannan J.D., Anderson S.D., Perry C.P. et al.: Aridol Study Group: The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness. Respir. Res. 2005, 6: 144.
12. Anderson S.D., Charlton B., Weiler J.M. et al.: A305 Study Group: Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Respir. Res. 2009, 23: 10-14.
13. Barben J., Roberts M., Chew N. et al.: Repeatability of bronchial responsiveness to mannitol dry powder in children with asthma. Pediatr. Pulmonol. 2003, 36: 490-494.
14. Barben J., Kuehni C.E., Strippoli M.P. et al.: Swiss Paediatric Respiratory Research Group: Mannitol dry powder challenge in comparison with exercise testing in children with asthma. Pediatric Pulmonol. 2011, 46(9): 842-848.
15 . Barben J., Strippoli M.P., Trachsel D. et al.: Effect of mannitol dry powder challenge on exhaled nitric oxide inchildren. PLOS ONE 2013, 8(1).
16. Brannan J.D., Perry C.P., Anderson S.D.: Mannitol test results in asthmatic adults receiving inhaled corticosteroids. J. Allergy Clin. Immunol. 2013, 131(3): 906-907.
17. Antolin-Amerigo D., Sanchez-Gonzalez M.J., Rodriguez-Rodriguez M. et al.: Asthma diagnosis and treatment. The utility of mannitol challenge in the assessment of asthma. World Allergy Organ. J. 2013, 23(suppl. 1): P4.
18. Porsbjerg C., Sverrild A., Backer V.: The usefulness of the mannitol challenge test for asthma. Expert Rev. Respir. Med. 2013, 7(6): 655-663.
19. Cockcroft D.W.: Direct challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010, 138(suppl. 2): 18-24.
20. Manoharan A., Lipworth B., Craig E. et al.: The potential role of direct and indirect bronchial challenge testing to identify overtreatment of community managed asthma. Clin. Exp. Allergy 2014 Jun 10 [https://doi.org/10.1111/cea.12352].
21. Kim M.H., Song W.J., Kim T.W. et al.: Diagnostic properties of the methacholine and mannitol bronchial challenge tests: a comparison study. Respirology 2014, 19(6): 852-856.
22. Świebocka E.M., Siergiejko G., Siergiejko Z.: Mannitol challenge does not confirm bronchial hyperreactivity in some histamine-responsive asthmatic children. J. Asthma 2012, 49(8): 817-821.
23. American Thoracic Society: Guidelines for methacholine and exercise challenge testing – 1999. Am. J. Respir. Crit. Care Med. 2000, 161: 309-329.
24. Anderson W.J., Lipworth B.J.: Relationship of mannitol challenge to methacholine challenge and inflammatory markers in persistens asthmatics receiving inhaled corticosteroids. Lung 2012, 190(5): 513-521.
25. Alblooshi A.S., Simpson S.J., Stick S.M. et al.: The safety and feasibility of the inhaled mannitol challenge test in young children. Eur. Respir. J. 2013, 42(5): 1420-1423.
26. Kalliola S., Malmberg L.P., Kajosaari M. et al.: Assessing direct and indirect airway hyperresponsiveness in children using impulse oscillometry. Ann. Allergy Asthma Immunol. 2014, 29: S1081-1206.
27. Nowowiejska B., Tomalak W., Radliński J. et al.: Transient reference values for impulse oscillometry for children aged 3-18 years. Pediatr. Pulmonol. 2008, 43(12): 1193-1197.
28. Horsman T.A., Duke R.K., Davenport P.W.: Airway response to mannitol challenge in asthmatic children using impulse oscillometry. J. Asthma 2009, 46(6): 600-603.
29. McClean M.A., Htun C., King G.G. et al.: Cut-points for response to mannitol challenges using the forced oscillation technique. Respir. Med. 2011, 105(4): 533-540.
30. Aronsson D., Tufvesson E., Bjermer L.: Comparison of central and peripheral airway involvement before and during methacholine, mannitol and eucapnic hyperventilation challenges in mild asthmatics. Clin. Respir. J. 2011, 5(1): 10-18.
31. Anderson W.J., Short P.M., Williamson P.A. et al.: Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial. Chest 2012, 142(6): 1553-1561.
32. Romberg K.A., Berggren A.C., Bjermer L.: Asthma control in patients on fixed dose combination evaluated with mannitol challenge test. Respir. Med. 2014, 108(2): 264-270.
33. Kippelen P., Tufvesson E., Ali L. et al.: Urinary CC16 after challenge with dry air hyperpnoea and mannitol in recreational summer athletes. Respir. Med. 2013, 107(12): 1837-1844.
34. Osthoff M., Michel F., Strupler M. et al.: Bronchial hyperresponsiveness testing in athletes of the Swiss Paralympic team. BMC Sports Sci. Med. Rehabil. 2013, 5(1): 7.